Dose reduction of biological therapies for inflammatory rheumatic diseases: what do patients think?

Scandinavian Journal of Rheumatology

Volumn 48, Issue 3, 2019, Pages 251-252

  Wallis, D ^a   Holmes, C ^a   Holroyd, C ^a   Sonpal, K ^a   Zarroug, J ^a   Adams, J ^b   Edwards, C J ^a  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL PRODUCT;

ANKYLOSING SPONDYLITIS; BIOLOGICAL THERAPY; DRUG DOSE REDUCTION; HUMAN; LETTER; PATIENT AUTONOMY; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; QUESTIONNAIRE; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; ADULT; DECISION MAKING; ETHICS; FEMALE; INFORMATION PROCESSING; MALE; MIDDLE AGED; OFF LABEL DRUG USE; PATIENT PARTICIPATION; PATIENT PREFERENCE; PROCEDURES; PSYCHOLOGY; UNITED KINGDOM;

ADULT; ARTHRITIS, RHEUMATOID; BIOLOGICAL THERAPY; DECISION MAKING; FEMALE; FOCUS GROUPS; HUMANS; MALE; MIDDLE AGED; OFF-LABEL USE; PATIENT PARTICIPATION; PATIENT PREFERENCE; SPONDYLITIS, ANKYLOSING; SURVEYS AND QUESTIONNAIRES; UNITED KINGDOM;

EID: 85057537033     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.1080/03009742.2018.1533034     Document Type: Letter

References (7)

1. Edwards CJ, Fautrel B, Schulze-Koops H, Huizinga TWJ, Kruger K., Dosing down with biologic therapies: a systematic review and clinicians’ perspective. Rheumatology (Oxford) 2017;57:589.
2. Chan CK, Holroyd CR, Mason A, Zarroug J, Edwards CJ. Are there dangers in biologic dose reduction strategies? Autoimmun Rev 2016;15:742–6.
3. Lau CS, Gibofsky A, Damjanov N, Lula S, Marshall L, Jones H, et al. Down-titration of biologics for the treatment of rheumatoid arthritis: a systematic literature review. Rheumatol Int 2017;37:1789–98.
4. Smolen JS, Landewe R, Bijlsma J, Burmester G, Chatzidionysiou K, Dougados M, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis 2017;76:960–77.
5. Singh JA, Saag KG, Bridges SL, Jr., Akl EA, Bannuru RR, Sullivan MC, et al. American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol 2015;68:1–26.
6. Marks JL, Holroyd CR, Dimitrov BD, Armstrong RD, Calogeras A, Cooper C, et al. Does combined clinical and ultrasound assessment allow selection of individuals with rheumatoid arthritis for sustained reduction of anti-tumor necrosis factor therapy? Arthritis Care Res (Hoboken) 2015;67:746–53.
7. Garcia I, Portugal C, Chu LH, Kawatkar AA. Response rates of three modes of survey administration and survey preferences of rheumatoid arthritis patients. Arthritis Care Res (Hoboken) 2013;66:364–70.